Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05GFD
|
||||
Former ID |
DNC009034
|
||||
Drug Name |
(Sar)WTLNSAGYLLGPKK(Lys-decanoyl)K
|
||||
Indication | Discovery agent | Investigative | [529952] | ||
Structure |
Download2D MOL |
||||
Formula |
C98H161N23O23
|
||||
Canonical SMILES |
CCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN<br />)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)<br />C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O<br />)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=<br />O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC
|
||||
InChI |
1S/C98H161N23O23/c1-11-12-13-14-15-16-17-36-80(126)105-44-27-23-34-69(88(133)111-67(85(103)130)31-20-24-41-99)113-89(134)68(32-21-25-42-100)112-90(135)70(33-22-26-43-101)114-96(141)77-35-28-45-121(77)82(128)54-108-87(132)71(46-57(2)3)115-91(136)72(47-58(4)5)116-93(138)74(49-62-37-39-64(124)40-38-62)110-81(127)53-107-86(131)60(8)109-95(140)76(56-122)119-94(139)75(51-79(102)125)117-92(137)73(48-59(6)7)118-98(143)84(61(9)123)120-97(142)78(144-83(129)55-104-10)50-63-52-106-66-30-19-18-29-65(63)66/h18-19,29-30,37-40,52,57-61,67-78,84,104,106,122-124H,11-17,20-28,31-36,41-51,53-56,99-101H2,1-10H3,(H2,102,125)(H2,103,130)(H,105,126)(H,107,131)(H,108,132)(H,109,140)(H,110,127)(H,111,133)(H,112,135)(H,113,134)(H,114,141)(H,115,136)(H,116,138)(H,117,137)(H,118,143)(H,119,139)(H,120,142)/t60-,61+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,84-/m0/s1
|
||||
InChIKey |
PSJWDZZPEFDHOW-QSNPNBGOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Galanin receptor type 1 | Target Info | Inhibitor | [529952] | |
Galanin receptortype 2 | Target Info | Inhibitor | [529952] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.